Literature DB >> 21842335

Time to revisit the orphan drug law.

Silvio Garattini.   

Abstract

Mesh：

Year:  2011        PMID： 21842335     DOI： 10.1007/s00228-011-1115-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Orphan drug pricing may warrant a competition law investigation.

Authors:  Jonathan C P Roos; Hanna I Hyry; Timothy M Cox
Journal:  BMJ       Date:  2010-11-16

2.  Orphan drug development is progressing too slowly.

Authors:  Roberta Joppi; Vittorio Bertele; Silvio Garattini
Journal:  Br J Clin Pharmacol       Date:  2006-03       Impact factor: 4.335

3.  Orphan drug development is not taking off.

Authors:  Roberta Joppi; Vittorio Bertele; Silvio Garattini
Journal:  Br J Clin Pharmacol       Date:  2009-01-21       Impact factor: 4.335

Review 4.  European regulation on orphan medicinal products: 10 years of experience and future perspectives.

Authors:  Kerstin Westermark; Birthe Byskov Holm; Mirjam Söderholm; Jordi Llinares-Garcia; Frida Rivière; Stiina Aarum; Florence Butlen-Ducuing; Stelios Tsigkos; Agnieszka Wilk-Kachlicka; Cinzia N'Diamoi; János Borvendég; David Lyons; Bruno Sepodes; Brigitte Bloechl-Daum; André Lhoir; Mariana Todorova; Ioannis Kkolos; Kateřina Kubáčková; Heidrun Bosch-Traberg; Vallo Tillmann; Veijo Saano; Emmanuel Héron; Rembert Elbers; Miranda Siouti; Judit Eggenhofer; Patrick Salmon; Maurizio Clementi; Dainis Krieviņš; Aušra Matulevičiene; Henri Metz; Albert Cilia Vincenti; Albertha Voordouw; Bożenna Dembowska-Bagińska; Ana Corrêa Nunes; Flavia Mirela Saleh; Tatiana Foltánová; Martin Možina; Josep Torrent i Farnell; Björn Beerman; Segundo Mariz; Marie Pauline Evers; Lesley Greene; Sigurdur Thorsteinsson; Lars Gramstad; Maria Mavris; Fabrizia Bignami; Annie Lorence; Chantal Belorgey
Journal:  Nat Rev Drug Discov       Date:  2011-05       Impact factor: 84.694
  4 in total
  5 in total

1.  Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU.

Authors:  Roberta Joppi; Vittorio Bertele'; Silvio Garattini
Journal:  Eur J Clin Pharmacol       Date:  2012-10-23       Impact factor: 2.953

Review 2.  Involving patients in reducing decision uncertainties around orphan and ultra-orphan drugs: a rare opportunity?

Authors:  Devidas Menon; Tania Stafinski; Andrea Dunn; Hilary Short
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

3.  Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework.

Authors:  Mike Paulden; Tania Stafinski; Devidas Menon; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2015-03       Impact factor: 4.981

4.  Payers' Views of the Changes Arising through the Possible Adoption of Adaptive Pathways.

Authors:  Michael Ermisch; Anna Bucsics; Patricia Vella Bonanno; Francis Arickx; Alexander Bybau; Tomasz Bochenek; Marc van de Casteele; Eduardo Diogene; Jurij Fürst; Kristina Garuolienė; Martin van der Graaff; Jolanta Gulbinovič; Alan Haycox; Jan Jones; Roberta Joppi; Ott Laius; Irene Langner; Antony P Martin; Vanda Markovic-Pekovic; Laura McCullagh; Einar Magnusson; Ellen Nilsen; Gisbert Selke; Catherine Sermet; Steven Simoens; Robert Sauermann; Ad Schuurman; Ricardo Ramos; Vera Vlahovic-Palcevski; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-09-28       Impact factor: 5.810

Review 5.  Personalizing health care: feasibility and future implications.

Authors:  Brian Godman; Alexander E Finlayson; Parneet K Cheema; Eva Zebedin-Brandl; Inaki Gutiérrez-Ibarluzea; Jan Jones; Rickard E Malmström; Elina Asola; Christoph Baumgärtel; Marion Bennie; Iain Bishop; Anna Bucsics; Stephen Campbell; Eduardo Diogene; Alessandra Ferrario; Jurij Fürst; Kristina Garuoliene; Miguel Gomes; Katharine Harris; Alan Haycox; Harald Herholz; Krystyna Hviding; Saira Jan; Marija Kalaba; Christina Kvalheim; Ott Laius; Sven-Ake Lööv; Kamila Malinowska; Andrew Martin; Laura McCullagh; Fredrik Nilsson; Ken Paterson; Ulrich Schwabe; Gisbert Selke; Catherine Sermet; Steven Simoens; Dominik Tomek; Vera Vlahovic-Palcevski; Luka Voncina; Magdalena Wladysiuk; Menno van Woerkom; Durhane Wong-Rieger; Corrine Zara; Raghib Ali; Lars L Gustafsson
Journal:  BMC Med       Date:  2013-08-13       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.